Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Diabetes Care Devices Market, by Product
1.4.2 North America Diabetes Care Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct – 2022, May) Leading Players
Chapter 4. North America Diabetes Care Devices Market by Product
4.1 North America Insulin Delivery Devices Market by Country
4.2 North America Blood Glucose Monitoring Devices Market by Country
Chapter 5. North America Diabetes Care Devices Market by Country
5.1 US Diabetes Care Devices Market
5.1.1 US Diabetes Care Devices Market by Product
5.2 Canada Diabetes Care Devices Market
5.2.1 Canada Diabetes Care Devices Market by Product
5.3 Mexico Diabetes Care Devices Market
5.3.1 Mexico Diabetes Care Devices Market by Product
5.4 Rest of North America Diabetes Care Devices Market
5.4.1 Rest of North America Diabetes Care Devices Market by Product
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 DexCom, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.2.5.3 Acquisition and Mergers:
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental & Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Sanofi S.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Zealand Pharma A/S (Valeritas, Inc.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expenses
6.5.4 Recent strategies and developments:
6.5.4.1 Product Launches and Product Expansions:
6.5.4.2 Approvals and Trials:
6.6 B. Braun Melsungen AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Bayer AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.5.2 Approvals:
6.9 Ypsomed AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.10. Arkray, Inc.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Geographical Expansions:



List of Tables

TABLE 1 North America Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 2 North America Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Diabetes Care Devices Market
TABLE 4 Product Launches And Product Expansions– Diabetes Care Devices Market
TABLE 5 Acquisition and Mergers– Diabetes Care Devices Market
TABLE 6 Geographical expansion– Diabetes Care Devices Market
TABLE 7 Approvals and Trials– Diabetes Care Devices Market
TABLE 8 North America Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 9 North America Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 10 North America Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
TABLE 16 US Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 17 US Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 18 US Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 19 US Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 20 Canada Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 21 Canada Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 22 Canada Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 23 Canada Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 24 Mexico Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 25 Mexico Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 26 Mexico Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 27 Mexico Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 28 Rest of North America Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 29 Rest of North America Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 30 Rest of North America Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 31 Rest of North America Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 32 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 33 Key Information – DexCom, Inc.
TABLE 34 Key information – Novo Nordisk A/S
TABLE 35 Key Information – Sanofi S.A.
TABLE 36 Key Information – Zealand Pharma A/S
TABLE 37 key Information – B. Braun Melsungen AG
TABLE 38 Key Information – Bayer AG
TABLE 39 Key Information – Abbott Laboratories
TABLE 40 Key Information –-Ypsomed AG
TABLE 41 Key Information – Arkray, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct – 2022, may) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 6 Recent strategies and developments: DexCom, Inc.
FIG 7 Recent strategies and developments: Novo Nordisk A/S
FIG 8 Recent strategies and developments: Sanofi S.A.
FIG 9 Recent strategies and developments: Zealand Pharma A/S
FIG 10 Recent strategies and developments: Arkray, Inc.